RT Journal Article
SR Electronic
T1 Lower respiratory tract myeloid cells harbor SARS-CoV-2 and display an inflammatory phenotype
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.11.20171967
DO 10.1101/2020.08.11.20171967
A1 William Bain
A1 Hernán F. Peñaloza
A1 Mark S. Ladinsky
A1 Rick van der Geest
A1 Mara Sullivan
A1 Mark Ross
A1 Georgios D. Kitsios
A1 Barbara Methe
A1 Bryan J. McVerry
A1 Alison Morris
A1 Alan M. Watson
A1 Simon C. Watkins
A1 Claudette M. St Croix
A1 Donna B. Stolz
A1 Pamela J. Bjorkman
A1 Janet S. Lee
YR 2020
UL http://medrxiv.org/content/early/2020/08/14/2020.08.11.20171967.abstract
AB SARS-CoV-2 pneumonia may induce an aberrant immune response with brisk recruitment of myeloid cells into the lower respiratory tract, which may contribute to morbidity and mortality. We describe endotracheal aspirate samples from seven patients with SARS-CoV-2 pneumonia requiring mechanical ventilation. We note SARS-CoV-2 virions within lower respiratory tract myeloid cells shown by electron tomography, immunofluorescence confocal imaging, and immuno-electron microscopy. Endotracheal aspirates are primarily composed of mononuclear and polymorphonuclear leukocytes. These myeloid cells that harbor virus are frequently positive for CD14 and/or CD16 and most display an inflammatory phenotype marked by expression of IL-6 and tissue factor mRNA transcript and protein expression.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Career Development Award Number IK2 BX004886 from the United States Department of Veterans Affairs Biomedical Laboratory R&D (BLRD) Service (W.B.); the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Numbers K23 HL129987 (G.D.K); P01HL114453 (J.S.L., B.J.M.); and R01 HL136143, R01 HL142084, K24 HL143285 (J.S.L.). Electron and confocal microscopy at the University of Pittsburgh Center for Biologic Imaging was supported by National Institutes of Health Office of the Director awards S10OD010625 and S10OD019973 (S.C.W.). Electron tomography at the California Institute of Technology was supported by a George Mason University Fast Grant (P.J.B.), National Institute of Allergy and Infectious Diseases (NIAID) Grant 2 P50 AI150464 (P.J.B.), and that EM was performed using a TF-30 electron microscope maintained by the California Institute of Technology Kavli Nanoscience Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, Department of Veterans Affairs, or any other sponsoring agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Pittsburgh Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data is provided within the manuscript. Requests for additional data should be directed to the corresponding author.